$XNCR News Article - Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies
https://marketwirenews.com/news-releases/xenc...94206.html